Comparison of GnRH antagonists and flareup GnRH agonists in donor oocyte cycles

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 53, Issue 3, 2008, Pages 147-150

  Wei, Alex Y ^a   Mijal, Katherine A ^a   Christianson, Mindy S ^a   Schouweiler, Calisa M ^a   Lindheim, Steven R ^a  

^a 44/628 CSC ^*

Author keywords

Embryo transfer; Gonadotropin releasing hormone; Hormone antagonists; In vitro fertilization; Oocyte donation

Indexed keywords

ESTROGEN; FOLLITROPIN; PROGESTERONE;

ARTICLE; CELL CYCLE; CRYOPRESERVATION; DISEASE SEVERITY; EMBRYO TRANSFER; FERTILIZATION; HORMONE BLOOD LEVEL; HUMAN; OOCYTE; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL;

ADULT; EMBRYO IMPLANTATION; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; MIDDLE AGED; OOCYTE DONATION; OVULATION INDUCTION; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 41849137578     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Insler V, Lunenfeld E, Potashnik G, et al: The combined pituitary suppression/ovarian stimulation therapy: Myths and realities. In Advances in Assisted Reproductive Technologies. Edited by S Mashiach, Z Ben-Rafael, N Laufer, et al. New York, Plenum Press, 1990, pp 31-46
2. Cassidenti DL, Sauer MV, Paulson RJ, et al: Comparison of intermittent and continuous use of a gonadotropin-releasing hormone antagonist (Nal-Glu) in in-vitro fertilization cycles: A preliminary report. Am J Obstet Gynecol 1991;165:1806-1810
3. Frydman R, Cornel C, De Ziegler D, et al: Prevention of premature luteinizing hormone and progesterone rise with a LH-RH antagonist, Nal-Glu, in controlled ovarian hyperstimulation. Fertil Steril 1991;56:923-927
4. Rabinovici J, Rothman P, Monroe SE, et al: Endocrine effects and pharmacokinetic characteristics of a potent new gonadotropin-releasing hormone antagonist (Ganirelix) with minimal histamine-releasing properties: Studies in postmenopausal women. J Clin Endocrinol Metab 1992;75:1220-1225
5. de Jong D, Macklon, NS, Mannaerts BM, et al: High dose gonadotropin-releasing hormone antagonist (ganirelix) may prevent ovarian hypersrimulation caused by ovarian stimulation for in-vitro fertilization. Hum Reprod 1998;13:573-575
6. Felberbaum RE, Diedrich K: Ovarian stimulation for IVF/ICSI with gonadotropins and GnRH analogues: Agonist and antagonist. Hum Reprod (suppl 1) 1999;14:207-221
7. The European Orgalutran Study Group: Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe, and convenient: results of a controlled, randomized, multicentre trial. Hum Reprod 2001;15:1490-1498
8. Fauser B, Devroey P: Why is the clinical acceptance of gonadotropin-releasing hormone antagonist co-treatment during ovarian hyperstimulation for in vitro fertilization so slow? Fertil Steril 2005;83:1607-1611
9. Al Inany H, Aboulghar M: GnRH antagonist in assisted reproduction: A Cochrane review. Hum Reprod 2002;17:874-875
10. Garcia JE, Padilla SL, Bayati J, et al: Follicular phases gonadotropin-releasing hormone agonist and human gonadotropins: A better alternative for ovulation induction in vitro fertilization. Fertil Steril 1990;53:302-305
11. Jacobson A, Galen D, Milani H, et al: A novel super ovulation regimen: Three-day gonadotropin-releasing hormone agonist with overlapping gonadotropins. Fertil Steril 1991;56:1169-1172
12. Padilla SL, Smith RD, Garcia JE: The Lupron screening test: Tailoring the use of leuprolide acetate in ovarian stimulation for in vitro fertilization. Fertil Steril 1991;56:79-83
13. Scott R, Navot D: Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril 1994;64:880-885
14. Sauer MV: Oocyte donation; reviewing a decade of growth and development. Semin Reprod Endocrinol 1995;13:79-84
15. Bodri D, Vernaeve V, Guillen JJ, et al: Comparison between a GnRH antagonist and a GnRH agonist flareup protocol in oocyte donors: A randomized clinical trial. Hum Reprod 2006;21:2246-2251
16. Lindheim SR, Morales AJ: GnRH antagonists followed by a decline in serum estradiol results in adverse outcomes in donor oocyte cycles. Hum Reprod 2003;18:2048-2051
17. Ricciarelli E, Sanchez M, Martinez M, et al: Impact of the gonadotropin-releasing hormone antagonist in oocyte donation cycles. Fertil Steril 2003;73:18-22
18. Prapas N, Prapas Y, Panagiotidis Y, et al: GnRH agonist versus GnRH antagonist in oocyte donation cycles: A prospective randomized study. Hum Reprod 2005;20:1516-1520
19. Propst AM, Bates W, Robinson RD, et al: A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer. Fertil Steril 2006;86:58-63